CD8A and neoplasm: Here, we employed an orthotopic model of triple‐negative breast cancer (AT3) expressing the model antigen ovalbumin (OVA; AT3‐OVA), which generates protective tumor‐resident CD8+ TIL that are necessary for tumor control.19